The Science and Technology Committee evidence session in its inquiry into ‘Clinical trials’ on Wednesday 17 April at 9.00 a.m. has, as a result of the House agreeing to Sittings of the House (Wednesday 17 April) (Motion) on Tuesday 16 April, been rescheduled to:
Monday 22 April 2013
Committee Room 8 (to be confirmed)
At 5.15 pm
- Catherine Elliott, Director, Clinical Research Interests, Medical Research Council
- Sharmila Nebhrajani, Chief Executive, Association of Medical Research Charities
- Professor Peter Johnson, Chief Clinician, Cancer Research UK
- Representative from the Wellcome Trust;
At 6.15 pm
- Dr Bina Rawal, Director of Research, Medical and Innovation, Association of the British Pharmaceutical Industry
- Dr James Shannon, Chief Medical Officer, GlaxoSmithKline
- Mr William M. Burns, Member of the Board of Directors, Roche
Further evidence sessions will be announced in due course.
Follow @CommonsSTC
Image: sxc